한글목차

COVID-19 진단제를 포함한 세계 생명과학 툴 및 시약 시장 규모는 2023년 594억 달러, 2024년 532억 달러에서 예측 기간 동안 연평균 4.6% 성장하여 2029년 말에는 665억 달러에 달할 것으로 예상됩니다.

생명과학 툴 및 시약 부문은 2024년 513억 달러에서 연평균 5.3% 성장하여 2029년 664억 달러에 달할 것으로 예상됩니다. 또한, COVID-19 진단 검사 부문은 2024년 19억 달러에서 2029년 1억 730만 달러로 감소하여 2024-2029년 예측 기간 동안 마이너스 43.5%의 CAGR을 기록할 것으로 예상됩니다.

세계 생명과학 툴 및 시약 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 신흥 기술 및 기술 개발 동향, 시장 규모 추정 및 예측, 각 부문별·지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 개요

제2장 시장 개요

• 개요
• 생명과학의 제품 개발
• PESTLE 분석
• Porter's Five Forces 분석

제3장 시장 역학

• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 과제
• 시장 기회

제4장 신기술과 개발

• AI와 머신러닝
• IoT
• 데이터 수집 자동화
• 기기 추적
• 원격 분석
• 상호접속성
• 예측 보수
• 생명과학 실험실의 로봇
• 3D/4D 세포배양
• 유해 화학제품 사용 절감

제5장 시장 세분화 분석

• 부문별 내역
• 시장 분석 : 유형별
• COVID-19 진단 검사 시장
• 생명과학 툴 및 시약 시장
• 시장 내역 : 용도별
• 유전체학
• 단백질체학
• 세포생물학
• 줄기세포
• 이미징 툴과 기술
• 동물 모델
• 후생유전학 툴과 시약
• 생명과학 툴 및 시약
• 기타
• 지역적 내역
• 시장 내역 : 지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제6장 경쟁 정보

• 주요 기업 분석
• PCR 기술과 시약
• 마이크로플레이트 리더/ELISA 장비
• 항체
• ELISA 검사
• 생명과학 키트와 어세이
• COVID-19 진단
• 전략 분석
• 제품 소개
• 협업과 계약
• M&A
• 기타 전략적 전개

제7장 생명과학 툴 및 시약 시장의 지속가능성 : ESG 관점

• ESG : 소개
• 환경
• 사회 문제
• 지배구조
• 생명과학 툴 및 시약 업계의 ESG 퍼포먼스 분석
• 패키징
• ESG 리스크 평가
• ESG 관련 기회와 리스크
• BCC의 결론

제8장 부록

• 조사 방법
• 약어
• 정보 출처
• 기업 개요
• BD
• BIO-RAD LABORATORIES INC.
• DANAHER CORP.
• F. HOFFMANN-LA ROCHE LTD.
• MERCK KGAA
• PROMEGA CORP.
• QIAGEN
• REVVITY
• TAKARA BIO INC.
• THERMO FISHER SCIENTIFIC INC.

영문목차

The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.

The global market for life science tools and reagents is expected to grow from $51.3 billion in 2024 to reach $66.4 billion by 2029, at a CAGR of 5.3% during the forecast period of 2024-2029.

The global market for COVID-19 diagnostics tests is expected to decline from $1.9 billion in 2024 to reach $107.3 million by 2029, at a negative CAGR of 43.5% during the forecast period of 2024-2029.

Report Scope

This report provides an analysis of the market for life sciences tools and reagents, including the leading companies, their revenues, product portfolios and recent activities. It looks at the competitive landscape and market dynamics such as drivers, restraints and opportunities. It sizes of the current and future markets. The reagents studied are antibodies, enzyme-linked immunosorbent assay (ELISA) kits, protein reagents and probes. The life science instruments include hybridization systems, PCR, Western blotting instruments, and ELISA instruments. The regions whose markets are analyzed are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Markets are also analyzed by application.

Report Includes

• 85 data tables and 44 additional tables
• An analysis of the global markets for life science tools and reagents, including COVID-19 diagnostics products
• Analyses of the global market trends, with market revenue data (sales figures) from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
• An estimate of the market size and revenue forecast for the market for life science tools and diagnostics, and a corresponding market share analysis based on product type, application and region
• Highlights of the current and future market potential of life science tools and diagnostics, along with an analysis of the competitive landscape, regulatory scenario and technological advances
• Facts and figures pertaining to the market dynamics, opportunities and deterrents, emerging technologies, future prospects and the impacts of macroeconomic variables
• An assessment of current products and identification of new potential markets for novel products and assay development
• A discussion on how scientific trends, government policies and the economy in general affect this market, as well as how the life science tools and diagnostics industry differs from the pharmaceutical and drug discovery industry
• A discussion of sustainability trends in the market, with emphasis on consumer attitudes, an analysis of companies' ESG scores, the future of ESG, case studies, and the ESG practices of leading companies
• An analysis of the key patent grants and recently published patents
• Identification of the major vendors along with an analysis of the competitive landscape, including company market shares, recent M&A activity and the outlook for venture funding
• Profiles of the leading market players, including Thermo Fisher Scientific, Danaher Corp., Merck KGaA, Roche and Qiagen

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Product Development in Life Science
• PESTLE Analysis
• Political
• Economic
• Social
• Technological
• Environmental
• Legal
• Environmental
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential for New Entrants
• Threat of Substitutes
• Competition in the Industry

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• Increasing Investments in R&D
• Diagnostic Pathways
• Prevalence of Chronic Diseases
• Broadening Range of Applications
• Market Restraints
• End of COVID-19 pandemic
• Cybersecurity
• Lack of Reproducibility of Antibodies
• Market Challenges
• End Users and Regulatory Compliance
• Market Opportunities
• Infectious Diseases on the Rise
• New Technologies

Chapter 4 Emerging Technologies and Developments

• AI and Machine Learning
• Internet of Things (IoT)
• Automation of Data Collection
• Tracking of Equipment
• Remote Analysis
• Interconnectivity
• Predictive Maintenance
• Robots in Life Science Labs
• 3D/4D Cell Culturing
• Reduced Use of Harmful Chemicals

Chapter 5 Market Segmentation Analysis

• Segmental Breakdown
• Market Analysis by Type
• COVID-19 Diagnostic Tests Market
• Market for Life Science Tools and Reagents
• Market Breakdown by Application
• Genomics
• Proteomics
• Cell Biology
• Stem Cells
• Imaging Tools and Techniques
• Animal Models
• Epigenetics Tools and Reagents
• Metabolomics
• Other Applications
• Geographic Breakdown
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Analysis of Leading Companies
• PCR Technologies and Reagents
• Microplate Readers/ELISA Instruments
• Antibodies
• ELISA Tests
• Life Science Kits and Assays
• COVID-19 Diagnostics
• Strategic Analysis
• Product Introductions
• Collaborations and Agreements
• Mergers and Acquisitions
• Other Strategic Developments

Chapter 7 Sustainability in the Life Sciences Tools and Reagents Market: An ESG Perspective

• Introduction to ESG
• Environment
• Social Issues
• Governance
• ESG Performance Analysis in the Life Science Tools and Reagents Industry
• Packaging
• ESG Risk Ratings
• ESG-related Opportunities and Risks
• Concluding Remarks from BCC Research

Chapter 8 Appendix

• Methodology
• Abbreviations
• Sources
• Company Profiles
• BD
• BIO-RAD LABORATORIES INC.
• DANAHER CORP.
• F. HOFFMANN-LA ROCHE LTD.
• MERCK KGAA
• PROMEGA CORP.
• QIAGEN
• REVVITY
• TAKARA BIO INC.
• THERMO FISHER SCIENTIFIC INC.